Search Clinical Trials
 
By Condition
 
By Location (USA)
 
By Location (Other)
 
By Sponsor
 
Resources
 
Privacy Policy
 
About Us
Disclaimer
A Phase I Study of Recombinant CD4(rCD4) in Patients With AIDS and AIDS-Related Complex Clinical Trials Resources presented on Clinical Trials Search is not meant to be a substitute for proven health advice, calls or treatment with a real medical. We aren't mDs. Always consult your doctor on A Phase I Study of Recombinant CD4(rCD4) in Patients With AIDS and AIDS-Related Complex conditions. Clinical Trials Search.org is a website dedicated to listing clinical research studies in human subjects. A Phase I Study of Recombinant CD4(rCD4) in Patients With AIDS and AIDS-Related Complex Clinical research trials and A Phase I Study of Recombinant CD4(rCD4) in Patients With AIDS and AIDS-Related Complex healthcare trials take place in a lot of of localities throughout the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically assess the effectiveness of new does drugs. The function of the studies / projects is to figure out specific human medical questions. Clinical trials are a popular means for doctors, government agencies, and private sector corporations to find cures for all varieties of conditions, like A Phase I Study of Recombinant CD4(rCD4) in Patients With AIDS and AIDS-Related Complex. A Phase I Study of Recombinant CD4(rCD4) in Patients With AIDS and AIDS-Related Complex Clinical Trials and other clinical trials allow volunteers to access health treatment options before they are available to the masses. Many times the subjects receive professional assistance for free, and every now and again they are compensated for their time. Sometimes there is a cost for a A Phase I Study of Recombinant CD4(rCD4) in Patients With AIDS and AIDS-Related Complex clinical trial. Human subjects often obtain the finest healthcare possible for their A Phase I Study of Recombinant CD4(rCD4) in Patients With AIDS and AIDS-Related Complex condition. Hazards are a reality, nevertheless, and might include additional or frequent dr. calls, health hazards (potentially life-jeopardizing), and/or the treatment being uneffective. Trials are federally regulated with stern guidelines to protect clinical trials patients.

Home > "A" Clinical Trials Conditions > A Phase I Study of Recombinant CD4(rCD4) in Patients With AIDS and AIDS-Related Complex

A Phase I Study of Recombinant CD4(rCD4) in Patients With AIDS and AIDS-Related Complex



A Phase I Study of Recombinant CD4(rCD4) in Patients With AIDS and AIDS-Related Complex

For Condition: HIV Infections
Status: Completed
Sponsor(s): Genentech ,
Synopsis: To determine the safety profile and maximum tolerated dose (MTD) of recombinant soluble human CD4 (rCD4) therapy in patients with AIDS or AIDS related complex (ARC). To obtain a preliminary indication of the antiviral effects of rCD4 in patients with AIDS and ARC. To measure steady state serum levels of rCD4 following continuous infusion therapy.
Details:
Eligibility:
Study Type:  Interventional, Treatment, Dose Comparison, Pharmacokinetics Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria Patients must have: - HIV-1 seropositivity. - Diagnosis of AIDS or AIDS related complex (ARC). - Failure to tolerate or respond to zidovudine (AZT) or decided to decline AZT therapy. - The ability to sign a written informed consent form prior to treatment. - A willingness to abstain from all other experimental therapy for HIV infection during the entire study period. - A life expectancy of at least 3 months. Exclusion Criteria Co-existing Condition: Patients with the following conditions or symptoms are excluded: - Serious active opportunistic infections. - Malignancies other than Kaposi's sarcoma. Concurrent Medication: Excluded: - Zidovudine (AZT). - Corticosteroids. - Nonsteroidal anti-inflammatory agents (NSAI). - Other experimental therapy. Patients with the following are excluded: - Serious active opportunistic infections. - Malignancies other than Kaposi's sarcoma. Prior Medication: Excluded within 3 weeks of study entry: - Zidovudine (AZT). - Chemotherapy. - Immunomodulators. - Other experimental therapy.
Total Enrollment: 

Location and Contact Information:

Genentech Inc
San Francisco,  California,  94080
United States
 


Additional Information:
Study ID Numbers:  064B;  CO036g,Serial Number 002
Study Start Date: 
Record last reviewed: January 1990
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00002005

Other Hiv Infections Studies:
1. Preventing Sexual Transmission of HIV With Anti-HIV Drugs

2. Reducing the Transmission of HIV in China

3. Safety and Effectiveness of Administering an HIV Vaccine in the Groin versus the Arm

4. A Phase I/II Trial to Assess the Safety and Tolerance of Escalating Doses of a Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Retinitis

5. A Study of Azithromycin in the Prevention of Mycobacterium avium Complex Disease (MAC) in HIV-Infected Patients

Related Studies:

Other HIV Infections Clinical Trials
Other California Clinical Trials
Other San Francisco Clinical Trials

A Phase I Study of Recombinant CD4(rCD4) in Patients With AIDS and AIDS-Related Complex
Modify your Search

  Other HIV Infections Clinical Trials
  Other California Clinical Trials
  Other San Francisco Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103